Clinical Trial Update: Study to Evaluate Efficacy and Safety of S303 Treated Red Blood Cells (RBCs)in Subjects With Thalassemia Major Requiring Chronic RBC Transfusion [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of S303-treated red blood cells in subjects with thalassemia major requiring chronic transfusions has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thalassemia Major

Drugs mentioned

• S303 Treated Red Blood Cells

Snippet

Sponsor: Cerus Corporation | Conditions: Thalassemia Major | Phase 3 | Status: COMPLETED